search
Compound Interest
Trends
- 1Micellar Formulation Boosts Xanthohumol Absorption in Human Trial●New Human Trial Shows Micellar Formulation Sharply Increases Xanthohumol Absorption
A new human trial has found that a micellar formulation sharply increases the absorption of xanthohumol, a compound derived from hops that has drawn interest for its potential health benefits. The findings suggest micellar delivery technology could make xanthohumol supplements significantly more bioavailable, a development likely to attract attention from supplement makers and nutrition researchers.
- 2Insilico Medicine picks AI-designed obesity drug candidate ISM1354▼Insilico Medicine nominates AI-designed ISM1354 GIPR antagonist for obesity
Drug discovery company Insilico Medicine has nominated ISM1354, an AI-designed GIPR antagonist, as a preclinical drug candidate for the treatment of obesity. The compound was developed using the firm's artificial intelligence drug discovery platform, adding to a growing pipeline of AI-generated molecules advancing toward clinical development for metabolic disease.